New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
08:41 EDTAUO, FL, SONC, LLY, FINL, FOLD, LULU, ARAYOn The Fly: Pre-market Movers
HIGHER AFTER GUIDANCE: Eli Lilly (LLY), up 1.7%... ALSO HIGHER: Amicus Theraputics (FOLD), up 8.5% after announcing results from Phase 2 study... AU Optronics (AUO), up 4.7% after DigiTimes said company asked to join Amazon supply chain... LOWER AFTER EARNINGS/GUIDANCE: Finish Line (FINL), down 7%... Sonic (SONC), down 5%... Accuray (ARAY), down 25.5%... ALSO LOWER: Foot Locker (FL), down 2% after disappointing results, guidance of peer Finish Line... lululemon (LULU), down 3.9% after downgrade to Neutral at Credit Suisse.
News For FINL;FL;LULU;LLY;AUO;FOLD;SONC;ARAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 16, 2015
10:00 EDTSONCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
April 15, 2015
17:26 EDTSONCSonic initiated with a Buy at Guggenheim
Target $37.
11:30 EDTSONCSonic management to meet with William Blair
Subscribe for More Information
07:41 EDTLLYEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 14, 2015
10:10 EDTFINLRunning Specialty Group enters exclusive agreement with PEAR Sports
Subscribe for More Information
05:46 EDTAUOReport: AUO may face $1B fine, probation for compliance issues, DigiTimes says
AU Optronics could face a $1B fine and five years of probation for allegedly failing to implement compliance policies, reports DigiTimes. Citing a report from Law360 that quoted prosecutors from the U.S. Attorney's Office, the fee comes after it was convicted of conspiring to fix pricing. The report added that AU Optronics responded by saying that it has already created compliance documents, trained more than 1,000 employees and hired a Chief Antritrust Compliance. Reference Link
April 10, 2015
11:03 EDTLLYEli Lilly granted orphan status for anal cancer treatment
Subscribe for More Information
April 9, 2015
16:05 EDTSONCSonic announces promotions in leadership team
Subscribe for More Information
09:25 EDTLLYPiper Jaffray pharmaceuticals analysts hold an analyst/industry conference call
Subscribe for More Information
09:18 EDTFLBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
06:41 EDTFINLPiper ups Under Armour target after meeting with Finish Line
Subscribe for More Information
April 8, 2015
10:01 EDTLULUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:27 EDTLULUlululemon rises moderately after upgrade, levels to watch
Subscribe for More Information
09:20 EDTLULUOn The Fly: Pre-market Movers
Subscribe for More Information
09:06 EDTLULUlululemon CFO, products leave favorable impression, says BB&T
Subscribe for More Information
07:44 EDTLULUlululemon upgraded at Sterne Agee
Subscribe for More Information
06:29 EDTLULUlululemon upgraded to Buy from Neutral at Sterne Agee
Subscribe for More Information
April 7, 2015
14:27 EDTLULUlululemon CFO impressive in meeting, says KeyBanc
KeyBanc said it was impressed by new lululemon CFO Stuart Haselden in a recent meeting and the firm believes his operational and financial experience should help the company keep improving its operations. The firm repeated that it views lululemon as one of the best product turnaround opportunities within its coverage and it maintains an Overweight rating on the stock.
07:14 EDTLLYEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
April 6, 2015
07:14 EDTLLYBiodel GEM device demonstrates 'superior' usability
Biodel (BIOD) announced results from a formative human factors study of its Glucagon Emergency Management, or GEM, device, which is in development for the treatment of diabetes patients experiencing severe hypoglycemia. In the study, the GEM device demonstrated a substantial improvement in ease-of-use and successful delivery of the full dose, as well as a reduction in dosing errors, when compared to commercially available glucagon kits; Eli Lilly's (LLY) Glucagon Emergency Rescue Kit and Novo Nordisk's GlucaGen HypoKit. Furthermore, while training and previous experience increased the success rate with the Eli Lilly and Novo Nordisk glucagon kits, it did not further impact the already high success rate with the GEM device when compared to non-experienced, untrained participants.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use